Pharmacokinetic-pharmacodynamic modeling of S(+)-KETamine in healthy volunteers

ISRCTN ISRCTN20522161
DOI https://doi.org/10.1186/ISRCTN20522161
Secondary identifying numbers N/A
Submission date
26/02/2007
Registration date
26/02/2007
Last edited
09/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Albert Dahan
Scientific

Leiden University Medical Centre (LUMC)
Department of Anesthesiology
P.O. Box 9600
Leiden
2300 RC
Netherlands

Phone +31 (0)71 526 2301
Email a.dahan@lumc.nl

Study information

Study designRandomised, placebo controlled, crossover, single blinded trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titlePharmacokinetic-pharmacodynamic modeling of S(+)-KETamine in healthy volunteers
Study acronymKET study
Study objectivesWe will investigate the relationship between S(+)-ketamine plasmaconcentrations and its analgesic effect to estimates the onset/offset times of ketamine and potency parameters for various analgesia tests. This will allow the safer administration of S(+) ketamine in clinical practice.
Ethics approval(s)Approval received from the Commissie Medische Ethiek on the 8th June 2006 (ref: WEC0604).
Health condition(s) or problem(s) studiedKetamine, analgesic
InterventionInfusion of S(+)-ketamine or placebo.

There are three infusion schemes:
1. In four subjects there will be two 30-minute infusions of S(+)-ketamine, separated by 30 minutes of no-infusion (end of infusion is at t = 90 min)
2. In four subjects there will be five 10-minute infusions of (S)+-ketamine, all separated by 10 minutes of no-infusion (end-of infusion is at t = 90 min)
3. In four subjects there will be three 20-minute infusions of S(+)-ketamine, all separated by 20 minutes of no-infusion (end of infusions is at t = 100 min)
4. As 1., but now placebo (NaCl 0.9%) will be infused
5. As 2., but now placebo (NaCl 0.9%) will be infused
6. As 3., but now placebo (NaCl 0.9%) will be infused
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)S(+)-ketamine
Primary outcome measureAnalgesia and plasma concentration of ketamine.
Secondary outcome measuresBowdle scale parameters.
Overall study start date01/02/2007
Completion date01/02/2008

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target number of participants24
Total final enrolment20
Key inclusion criteria1. Healthy volunteers 18+
Key exclusion criteria1. Obesity (Body Mass Index [BMI] more than 30)
2. Presence of medical disease (heart-, lung-, liver-, kidney-, neurological disease; diabetes m.; pyrosis; diaphragmatic hernia)
3. Presence of psychiatric disease
4. History of chronic alcohol or drug use
5. Allergy to study medications
6. Possibility of pregnancy
7. Lactation
Date of first enrolment01/02/2007
Date of final enrolment01/02/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Leiden University Medical Centre (LUMC)
Leiden
2300 RC
Netherlands

Sponsor information

Leiden University Medical Centre (LUMC) (The Netherlands)
Hospital/treatment centre

Department of Anaesthesiology
P.O. Box 9600
Leiden
2300 RC
Netherlands

Website http://www.lumc.nl/english/start_english.html
ROR logo "ROR" https://ror.org/027bh9e22

Funders

Funder type

Government

Trauma Related Neuronal Dysfunction (TREND) Fund (Germany) - a consortium sponsored by the ministry of economic affairs (http://www.crps.nl/)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2009 09/05/2019 Yes No

Editorial Notes

09/05/2019: Publication reference and total final enrolment added.